Leaderboard
Anzeige
Fr
|
De
Feedback
|
Impressum
|
Sitemap
Aucun choix d'articles!
Panier
Vous êtes ici:
Recherche de documentation spécialisée
»
Pancréas
»
Néoplasie
12. Octobre 2026
Recherche
Gastroplattform
Néoplasie
Recherche avancée
Dépistage / diagnostic
Traitements
Directives
Perfectionnement
Nouvelles
Recherche de documentation spécialisée
Voies biliaires
Foie
Estomac / intestins
Œsophage
Pancréas
Néoplasie
Pancréatite
Autres
Congrès et sessions
Services et outils
Liens
Rect Top
Anzeige
Écriture:
Page 1 de 3091
Articles 1 - 20 / 61808
Protocol for an immunocompetent KPC mouse model of pancreatic cancer resection and recurrence for perioperative treatment studies.
STAR Protoc
Léger JL, Amhis N, Mansouri S, Pacheco MFM, Daniel L, Giguère H, Collin Y, Tai LH.
PMID: 42858257 [PubMed - as supplied by publisher]
Molecular Profiling in Mucinous Pancreatic Cystic Neoplasms: Implications for Surgical Decision-Making - A Narrative Review.
J Vis Exp
Gao R, Gao Y, Jiao Y, Liu YH.
PMID: 42858026 [PubMed - indexed for MEDLINE]
Research progress of pancreatic cancer based on ferroptosis-cuproptosis interaction (Review).
Oncol Lett
Liu W, Ding M, Ji R, Qiao Z, Liu R, Chen P, Liu L.
PMID: 42857319 [PubMed]
Ginsenoside Rb1 From the Functional Food Panax ginseng Suppresses Pancreatic Cancer Progression via Macrophage Reprogramming Through the PI3K-AKT Pathway.
Food Sci Nutr
Dong CS, Wang G, Niu Y, Sun X, Ren W, Zhang J, Zhang Y, Wu RX, Wu X.
PMID: 42857277 [PubMed]
Clinical diagnostic value of serum CEA and CA19-9 in patients with advanced pancreatic cancer: A prognostic cohort study.
Front Oncol
Song J, Kang F, Ma L, Zhang A, Yang F, Liu Q.
PMID: 42856853 [PubMed]
Development of a predictive model for pancreatic cancer integrating serum metabolomics and polygenic risk score.
Front Endocrinol (Lausanne)
Wang X, Yang H, Li J, Wang X, Tong L, Han Z, Li Y, Liu M, Guo L, Zhou S, Ran Y, Zhao J, Zhou L.
PMID: 42856819 [PubMed - indexed for MEDLINE]
Cancer degronopathies and protein-fate biomarkers in drug resistance and cancer progression: signalling mechanisms, measurement and translational limits.
Front Cell Dev Biol
Li J, Liu S, Fu L, Bo Q, Bai Y, Dai X.
PMID: 42856810 [PubMed]
Landscape of cancer genomics and precision oncology in Japan, South Korea, China, and Australia.
Lancet Reg Health West Pac
Bando H, Okayama H, Chang YJ, Yu J, Grimmond SM, Kong SY, Hu X, Zeps N, Han JY, Kim JI, Seguchi K, Amisaki M, Sakamoto Y, Fujisawa T, Yamashita R, Kato K, Kono K, Johns A, Yoshino T.
PMID: 42856626 [PubMed]
Beyond target presence: A cross-cancer contextual framework for siRNA therapeutics in solid tumors.
Biochim Biophys Acta Rev Cancer
Zhao N, Zhang Y, Qian C, Zhang H, Wang L.
PMID: 42854878 [PubMed - as supplied by publisher]
Drastic muscle wasting following surgery is a strong predictor of prognosis in early-stage pancreatic cancer-a Taiwanese multicenter cohort study.
Cancer Treat Res Commun
Chen CY, Hou YC, Chao YJ, Kan NN, Wang MH, Liu YW, Lin YH, Wang CJ, Huang CJ, Chiu TJ, Yin SM, Shan YS.
PMID: 42854340 [PubMed - as supplied by publisher]
Giant cystic lymphangioma in the pancreatic tail-splenic hilum region managed by en bloc resection: A case report.
Medicine (Baltimore)
Wang Y, Xiong B, Niu J, Li S.
PMID: 42854074 [PubMed - indexed for MEDLINE]
Cancer-type-specific gaps between treatment recommendation and implementation following comprehensive genomic profiling: a nationwide real-world study.
Oncology
Nakano Y, Igarashi A, Esaki M.
PMID: 42853769 [PubMed - as supplied by publisher]
The sphingolipid code of cancer: divergent roles across tumor types and therapeutic horizons.
Mol Biol Rep
Thombre DG, Katre VA, Singh S, Vaish V.
PMID: 42853313 [PubMed - indexed for MEDLINE]
The early-onset pancreatic cancer paradox: a systematic review and meta-analysis.
J Natl Cancer Inst
Ruze R, Zayier M, Aboduhelili A, Tuergan T, Abulizi A, Guo Q, Zhang R, Shalayiadang P, Ahan A, Jiang T, Shao Y, Aji T.
PMID: 42853071 [PubMed - as supplied by publisher]
Discontinuing Surveillance of Low-Risk Branch-Duct Intraductal Papillary Mucinous Neoplasms in Routine Practice: An External Application of the "Trivial" Criteria and the Resources it Would Release in Fourteen Health Systems.
United European Gastroenterol J
Ricci C, D'Ambra V, Casarotto M, Alberici L, Ingaldi C, Fichera M, Mosconi C, Migliori M, Casadei R.
PMID: 42852691 [PubMed - indexed for MEDLINE]
cGAS‑STING pathway in digestive tract cancer: From molecular mechanisms to therapeutic applications (Review).
Int J Oncol
Chen T, Zhang J, Sun J, Zhang H, Huang D, Ye H.
PMID: 42852635 [PubMed - indexed for MEDLINE]
Socioeconomic Disparities in Supportive Care Medication Use Among US Medicare Beneficiaries with Pancreatic Cancer.
Cancer Control
Khalil H, Guo Y, Bian J, Guo J, Yang S, Lou X, Scarton L, Rogers SC, Wilkie DJ, DeRemer DL, Allen JM.
PMID: 42849050 [PubMed - indexed for MEDLINE]
The gut-pancreas axis: microbial dysbiosis as a pathogenic driver of diabetes and pancreatic cancer.
Med Oncol
Li Y.
PMID: 42848148 [PubMed - indexed for MEDLINE]
Improving predictive accuracy for surgical indication of the current management guideline for intraductal papillary mucinous neoplasm of the pancreas via cutoff adjustments.
Eur Radiol
Park J, Kim JH, Hong SJ.
PMID: 42848040 [PubMed - as supplied by publisher]
Advancements in polymer-based drug delivery systems targeting the tumor microenvironment for immunotherapy of triple-negative breast cancer.
Front Immunol
Wang Z, Li M, Wang Z, Wang Y.
PMID: 42846762 [PubMed - indexed for MEDLINE]
Articles 1 - 20 / 61808
Page 1 de 3091
Rect Bottom
Anzeige
Adserver Footer
Intervalle de temps demandé
--sans limitation--
1 Week
1 Month
3 Months
6 Months
1 Year
2 Years
3 Years
5 Years
10 Years
Sky right 1
Anzeige
Mediscope AG E-mail:
info@mediscope.ch
Disclaimer
|
Privacy Policy
|
Publicité